---
title: "BEguided platform evaluates base editors for precision single-nucleotide editing"
id: "biorxiv-3-beguided-systematic-guide-and-base-editor-evaluation-for-precision-single"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-3-beguided-systematic-guide-and-base-editor-evaluation-for-precision-single"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# BEguided platform evaluates base editors for precision single-nucleotide editing
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-3-beguided-systematic-guide-and-base-editor-evaluation-for-precision-single
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors developed **BEguided**, a computational platform that designs variant-specific guide RNAs and compares base-editor profiles across 38 predefined editors. - BEguided accepts user-defined editors and incorporates single-nucleotide variants directly into target sequences, avoiding the need for custom reference genomes. - A companion tool, BEguidedOFF, performs base-editing-aware off-target prediction tailored to the editors considered. - The team systematically assessed the 1,000 most frequent adenine-to-guanine–amenable cancer mutations for accessibility to **adenine base editing**. - Under stringent guide-quality, bystander-editing, and predicted off-target filters, only 7 mutations were targetable with **SpCas9-ABE8e**. - Expanding SpCas9-compatible adenine editors increased targetable mutations to 30. - Including SaCas9, relaxed-PAM Cas9-NG/SpG, and PAM-less **SpRY** progressively raised targetable mutation counts to 100, 156, and 238, respectively. - The analysis demonstrates that **editor selection** and PAM constraints materially influence which single-nucleotide variants are addressable by base editing. - BEguided and supporting code and datasets are available at the authors’ web and GitHub links; the preprint has not been peer reviewed. - The source did not report experimental bench-validation of editing outcomes, clinical data, detailed off-target validation assays, or regulatory milestones; those remain open questions.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=_jGEkIOI6jlCJmZoTVVM_PmbTmdRaVgJPSUS_0g6B6g-1795247021.7765563-1.2.1.1-F3vJ76DRAJJTSejIRTyiN9Xpunn9_aqjb3YcV4NqYKp_TMx4xDr.hnXmG7wi0Oic) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # BEguided: Systematic guide and base editor evaluation for precision single-nucleotide editing [ View ORCID Profile](http://orcid.org/0000-0002-5455-4901)Lukas Theo Schmitt, [ View ORCID Profile](http://orcid.org/0009-0004-0102-8133)Pascal Wang, Sara Orugo Medina, [ View ORCID Profile](http://orcid.org/0000-0003-0959-1954)Moustafa Abohawya, [ View ORCID Profile](http://orcid.org/0000-0002-4577-3344)Frank Buchholz, [ View ORCID Profile](http://orcid.org/0000-0002-3209-238X)Shady Sayed doi: https://doi.org/10.64898/2026.11.20.767841 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Lukas Theo Schmitt 1 Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lukas%2BTheo%2BSchmitt%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Schmitt%20LT&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALukas%2BTheo%2BSchmitt%2B) * [ORCID record for Lukas Theo Schmitt](http://orcid.org/0000-0002-5455-4901 "Open in new tab") * For correspondence: lukas_theo.schmitt@tu-dresden.de Pascal Wang 1 Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pascal%2BWang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Wang%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APascal%2BWang%2B) * [ORCID record for Pascal Wang](http://orcid.org/0009-0004-0102-8133 "Open in new tab") Sara Orugo Medina 1 Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sara%2BOrugo%2BMedina%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Medina%20SO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASara%2BOrugo%2BMedina%2B) Moustafa Abohawya 2 German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Moustafa%2BAbohawya%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Abohawya%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMoustafa%2BAbohawya%2B) * [ORCID record for Moustafa Abohawya](http://orcid.org/0000-0003-0959-1954 "Open in new tab") Frank Buchholz 1 Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Frank%2BBuchholz%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Buchholz%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AFrank%2BBuchholz%2B) * [ORCID record for Frank Buchholz](http://orcid.org/0000-0002-4577-3344 "Open in new tab") Shady Sayed 3 Mildred Scheel Early Career Center (MSNZ P^2^), Dresden, Germany. Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany. * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shady%2BSayed%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Sayed%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AShady%2BSayed%2B) * [ORCID record for Shady Sayed](http://orcid.org/0000-0002-3209-238X "Open in new tab") * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5982560/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5982560/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5982560/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5982560/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5982560/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Base editing enables precise nucleotide substitutions without introducing DNA double-strand breaks, but identifying optimal editor-guide combinations remains challenging because PAM compatibility, editing-window positioning, bystander modifications, and off-target effects must be considered simultaneously. Here, we introduce BEguided, an integrated computational platform for variant-specific guide RNA design and systematic comparison across 38 predefined base-editor profiles, with support for user-defined editors. BEguided incorporates single-nucleotide variants directly into target sequences, eliminating the need for customized reference genomes, while its companion tool, BEguidedOFF, provides base-editing-aware off-target prediction. To demonstrate the utility of this approach, we systematically assessed the accessibility of the 1,000 most frequent ABE-editable cancer mutations to adenine base editing. Under stringent guide-quality, bystander-editing, and predicted off-target criteria, only 7 mutations could be targeted using SpCas9-ABE8e. Expanding the analysis to additional SpCas9-compatible adenine base editors increased this number to 30, while inclusion of SaCas9, relaxed-PAM Cas9-NG/SpG variants, and PAM-less SpRY further expanded the number of potentially targetable mutations to 100, 156, and 238, respectively. These findings highlight the substantial impact of editor selection on mutation accessibility and establish BEguided as a versatile framework for identifying and prioritizing base-editing strategies for disease-associated variants. BEguided is available at https://beguided.buchholzlab.org. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * * * * ## Funder Information Declared Bundesministerium für Forschung, Technologie und Raumfahrt (BMFTR), 03VP13170, 01GL2405B Deutsche Forschungsgemeinschaft (DFG), 535486506, BU 1400/8-1 Deutsche Krebshilfe, 70117128 Berlin Institute of Health (BIH), nTTP-GCT Tandem Project Funding European Research Council (ERC), 101200794 EKFS grant ONCOnnect, 2022_EKMK.03 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-ND 4.0 International license](http://creativecommons.org/licenses/by-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.05.01.722161v2 "Wunen\(s\) help navigate Primordial Germ Cells by attenuating Hedgehog signaling")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.04.764252v2 "Quantitative Spatial Analysis of Matrix Remodelling in Wounds Using Digital Pathology and Fractal Analysis") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.20.767841v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.20.767841.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Data/Code](https://www.biorxiv.org/content/early/2026/11/20/2026.11.20.767841.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) BEguided: Systematic guide and base editor evaluation for precision single-nucleotide editing Lukas Theo Schmitt, Pascal Wang, Sara Orugo Medina, Moustafa Abohawya, Frank Buchholz, Shady Sayed bioRxiv 2026.11.20.767841; doi: https://doi.org/10.64898/2026.11.20.767841 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.767841v1%26text%3DBEguided%253A%2520Systematic%2520guide%2520and%2520base%2520editor%2520evaluation%2520for%2520precision%2520single-nucleotide%2520editing "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.767841v1%26t%3DBEguided%253A%2520Systematic%2520guide%2520and%2520base%2520editor%2520evaluation%2520for%2520precision%2520single-nucleotide%2520editing "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.767841v1%26title%3DBEguided%253A%2520Systematic%2520guide%2520and%2520base%2520editor%2520evaluation%2520for%2520precision%2520single-nucleotide%2520editing%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo]
## Related Clinical Research

- [Genomic survey reveals extensive biosynthetic gene clusters in Bionectriaceae cacao endophytes](https://medichelpline.com/clinical-feed/biorxiv-0-remarkable-biosynthetic-diversity-in-the-bionectriaceae-uncovering-the-genomic.md)
- [Nuclear quantum effects on ion permeation through the TRPM7 open pore: continuum-electrostatics es](https://medichelpline.com/clinical-feed/biorxiv-1-nuclear-quantum-effects-on-ion-permeation-through-the-open-transient-receptor.md)
- [Context-dependent roles of DJ-1 (PARK7) in oxidative-stress diseases: neuroprotection versus tumor](https://medichelpline.com/clinical-feed/pubmed-43059404.md) (DOI: 10.3892/mmr.2026.14076)
- [Cell-type X-chromosome Regulation Identifies Sex-Biased Genes Linked to Neurodegeneration](https://medichelpline.com/clinical-feed/medrxiv-16-brain-cell-type-specific-x-chromosome-gene-regulation-reveals-sex-biased.md)
- [Bilateral Carotid Artery Stenosis Linked to Slightly Higher Restless Legs Syndrome Risk](https://medichelpline.com/clinical-feed/medrxiv-23-carotid-artery-stenosis-is-associated-with-restless-legs-syndrome-in-the.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.